Buspirone in Reducing Shortness of Breath in Patients With Cancer
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Dyspnea, Pulmonary Complications, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Buspirone may be effective in reducing dyspnea (shortness of breath) in patients with cancer who are undergoing chemotherapy. PURPOSE: Randomized clinical trial to study the effectiveness of buspirone in reducing shortness of breath in patients who are undergoing chemotherapy for cancer.
Key facts
- Study ID
- NCT00053846
- Run by
- University of Rochester
- People needed
- 432
- Starts
- 2002-11-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2015-11-24
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- MBCCOP - University of Illinois at Chicago — Chicago, Illinois, United States
- CCOP - Central Illinois — Decatur, Illinois, United States
- CCOP - Evanston — Evanston, Illinois, United States
- CCOP - Wichita — Wichita, Kansas, United States
- CCOP - Kalamazoo — Kalamazoo, Michigan, United States
- CCOP - Kansas City — Kansas City, Missouri, United States
- CCOP - Nevada Cancer Research Foundation — Las Vegas, Nevada, United States
- CCOP - Hematology-Oncology Associates of Central New York — East Syracuse, New York, United States
- CCOP - Southeast Cancer Control Consortium — Goldsboro, North Carolina, United States
- CCOP - Dayton — Dayton, Ohio, United States
- CCOP - Columbia River Oncology Program — Portland, Oregon, United States
- CCOP - Greenville — Greenville, South Carolina, United States
- CCOP - Upstate Carolina — Spartanburg, South Carolina, United States
- CCOP - Northwest — Tacoma, Washington, United States
- CCOP - Marshfield Clinic Research Foundation — Marshfield, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.